What is the 13F Pro Quality Score for OSUR?

13F Pro ranks ORASURE TECHNOLOGIES INC (OSUR) on the 13F Pro Quality Score, a 0–100 composite of 32 fundamental signals including return on invested capital, free cash flow consistency, balance-sheet strength, earnings quality, growth durability, and valuation discipline. The score refreshes after each 10-K and 10-Q filing on SEC EDGAR. View OSUR's current score at https://13fpro.ai/company/OSUR (free sign-up required for the full ranking).

Which hedge funds own the most OSUR stock?

Based on the most recent Form 13F-HR filings on SEC EDGAR, the largest reported institutional holders of OSUR include BlackRock,, Neuberger Berman Group, PRIVATE MANAGEMENT GROUP. Holdings are reported quarterly within 45 days of quarter-end and updated on https://13fpro.ai/company/OSUR as soon as new 13F filings post.

Where does 13F Pro source OSUR data?

All ORASURE TECHNOLOGIES INC fundamentals and ownership data come directly from SEC EDGAR. ORASURE TECHNOLOGIES INC files with the SEC under CIK 1116463. 13F Pro ingests XBRL financial facts from 10-K and 10-Q filings, Form 13F-HR institutional holdings, and Form 4 insider transactions, with no third-party rewrites or estimates.

What sector is OSUR in?

ORASURE TECHNOLOGIES INC (OSUR) is classified in the Healthcare sector. 13F Pro publishes sector-level fund flow analysis and quality leaders at https://13fpro.ai/research/sector/healthcare.

How often is OSUR research updated on 13F Pro?

OSUR's fundamentals refresh within hours of each new 10-K or 10-Q filing on SEC EDGAR. Institutional ownership updates after each quarterly 13F filing window. Insider transactions update after each Form 4 filing. The 13F Pro Quality Score recalculates after every fundamentals refresh.

ORASURE TECHNOLOGIES INC(OSUR)Stock Analysis

AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →

Healthcare →Nasdaqsmall

Institutional-grade research for retail investors

SEC EDGAR: CIK 1116463 OSUR stock profile & AI dashboard →

13F Pro Quality Score

12.6/100

Rank #2,885 of 2,962 stocks

View Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.

Revenue Growth

1.2/100

Profitability

11.4/100

Balance Sheet

15.8/100

Earnings Quality

12.7/100

Free Cash Flow

10.1/100

Institutional Flow

12.0/100

Revenue Scale

17.3/100

Dilution Risk

17.7/100

Email me the moment this company reports earnings

AI Research Report

Two-page plain-English analysis: business, thesis, and three scenarios for the next two years. Refreshed every quarter.

Upgrade to Pro

Pro: 5 reports/month · Pro+: unlimitedOpinion, not investment advice. Do your own research.

Why OSUR Scores 13/100

exact factor attribution · 2026-09-11

OSUR's composite is held back by revenue growth and free cash flow. Bars show each factor's exact push vs. a median company, using the same weights the ranking engine applies.

Earnings growth

-0.3 pts

44th pct

Shareholder dilution

-1.6 pts

18th pct

Institutional flow

-1.9 pts

12th pct

Capital efficiency

-3.4 pts

16th pct

Earnings quality

-3.7 pts

13th pct

Scale

-4.9 pts

17th pct

Profitability

-5.8 pts

11th pct

Free cash flow

-6.0 pts

10th pct

Revenue growth

-9.8 pts

1th pct

Factor percentiles are cross-sectional ranks across the ~2,800-stock scored universe, computed from SEC EDGAR filings. Not investment advice.

OSUR Stock Analysis & AI Quality Score

Data updated 2026-09-11

AI stock analysis and institutional research for ORASURE TECHNOLOGIES INC (OSUR), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores OSUR at 12.6/100 on a 32-signal composite quality model, placing it at rank #2,885 of 2,962 stocks — the bottom half of the AI-ranked universe. Areas of concern include revenue growth (1.2) and free cash flow (10.1), which score below median versus the broader universe. Shareholder dilution risk is elevated at 17.7/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), ORASURE TECHNOLOGIES INC reports quarterly revenue of $30.6M, net income of $6.2M, free cash flow of $-12.3M. Top institutional holders of OSUR by reported 13-F value include BlackRock, Neuberger Berman Group, PRIVATE MANAGEMENT GROUP, based on the most recent SEC filings. OSUR trades on the Nasdaq exchange and files with the SEC under CIK 1116463. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate OSUR daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for ORASURE TECHNOLOGIES INC directly from SEC EDGAR. ORASURE TECHNOLOGIES INC's 13F Pro composite quality score has ranged between 13 and 70 since 2021, currently 12.6 — a declining long-term trajectory across 68 quarterly and live scoring snapshots.

✦

Fun facts about ORASURE TECHNOLOGIES INC

Quirks, history, and lore behind OSUR — the kind of stuff that makes a stock memorable.

1
The Basics
U.S. healthcare company · listed on Nasdaq · headquartered in Pennsylvania · focused on diagnostics and specimen collection.
2
The Numbers
Annual revenue in the range of a few hundred million dollars, with sales historically spiking during public health crises when demand for rapid testing surges.
3
The History
Founded in the late 1980s, the company built its early reputation around oral fluid diagnostics — a novel idea at a time when blood was the default.
4
The Secret
It pioneered an FDA-approved HIV test that uses a swab from your mouth instead of a needle — no blood, no lab, results in about 20 minutes.
5
The Lore
When COVID-19 hit, this small-cap company became a household name in public health circles almost overnight, supplying rapid antigen tests to governments and clinics worldwide.
6
The Giveaway
Its flagship consumer HIV test — sold at pharmacies as OraQuick — is the only at-home oral HIV test the FDA has ever approved. Spit, wait, know.

▶ Think you know your stocks? Play the Daily Ticker

Revenue

Q2 2026

$30.6M

Net Income

Q2 2026

$6.2M

Free Cash Flow

Q2 2026

$-12.3M

ROIC

Q2 2026

6.9%

Period

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro

Revenue

-38.1% YoY

$115.0MFY 2025

FY22 $387.5MFY23 $405.5MFY24 $185.8MFY25 $115.0M

Net Income

-252.5% YoY

$-68.7MFY 2025

FY22 $-17.1MFY23 $53.7MFY24 $-19.5MFY25 $-68.7M

Operating Income

-154.8% YoY

$-72.0MFY 2025

FY22 $-22.2MFY23 $32.7MFY24 $-28.3MFY25 $-72.0M

EPS (Diluted)

-261.5% YoY

$-0.94FY 2025

FY22 $-0.24FY23 $0.72FY24 $-0.26FY25 $-0.94

Total Assets

-15.9% YoY

$403.2MFY 2025

FY22 $444.2MFY23 $482.8MFY24 $479.7MFY25 $403.2M

Op. Cash Flow

-279.1% YoY

$-49.0MFY 2025

FY22 $-47.2MFY23 $141.6MFY24 $27.4MFY25 $-49.0M

Free Cash Flow

-325.7% YoY

$-53.2MFY 2025

FY22 $-54.0MFY23 $135.8MFY24 $23.6MFY25 $-53.2M

Metric	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Revenue	$115.0M -38.1%	$185.8M -54.2%	$405.5M +4.6%	$387.5M +65.8%	$233.7M +36.1%	$171.7M
Net Income	$-68.7M -252.5%	$-19.5M -136.3%	$53.7M +413.2%	$-17.1M +25.5%	$-23.0M -54.1%	$-14.9M
Operating Income	$-72.0M -154.8%	$-28.3M -186.4%	$32.7M +247.5%	$-22.2M -118.0%	$-10.2M -96.3%	$-5.2M
EPS (Diluted)	$-0.94 -261.5%	$-0.26 -136.1%	$0.72 +400.0%	$-0.24 +25.0%	$-0.32 -245.5%	$0.22
Total Assets	$403.2M -15.9%	$479.7M -0.7%	$482.8M +8.7%	$444.2M -3.6%	$461.0M +1.4%	$454.5M
Operating Cash Flow	$-49.0M -279.1%	$27.4M -80.7%	$141.6M +400.0%	$-47.2M -33.4%	$-35.4M -709.3%	$5.8M
Free Cash Flow	$-53.2M -325.7%	$23.6M -82.6%	$135.8M +351.6%	$-54.0M +5.8%	$-57.3M -174.5%	$-20.9M

Get alerted when OSUR's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for ORASURE TECHNOLOGIES INC including:

SEC EDGAR filings (10-K, 10-Q, 8-K)

XBRL financial facts (revenue, EPS, margins)

Insider transactions (Form 4)

Institutional 13F holdings

Quality rankings (32 signals)

AI analyst debates & daily meetings

Historical financial trends

Peer comparison & sector analysis

Top Institutional Holders of OSUR

BlackRock, Inc.
$27.9M6,256,762 sh
Neuberger Berman Group LLC
$20.9M4,685,432 sh
PRIVATE MANAGEMENT GROUP INC
$16.9M3,797,682 sh
Altai Capital Management, L.P.
$16.1M3,613,836 sh
VANGUARD CAPITAL MANAGEMENT LLC
$13.5M3,018,907 sh
SYSTEMATIC FINANCIAL MANAGEMENT LP
$12.7M2,857,974 sh
DIMENSIONAL FUND ADVISORS LP
$10.4M2,340,901 sh
ACADIAN ASSET MANAGEMENT LLC
$9.0M2,022,119 sh
RENAISSANCE TECHNOLOGIES LLC
$9.0M2,014,903 sh
GEODE CAPITAL MANAGEMENT, LLC
$8.1M1,807,889 sh

Fund	Value	Shares
BlackRock, Inc.	$27.9M	6,256,762
Neuberger Berman Group LLC	$20.9M	4,685,432
PRIVATE MANAGEMENT GROUP INC	$16.9M	3,797,682
Altai Capital Management, L.P.	$16.1M	3,613,836
VANGUARD CAPITAL MANAGEMENT LLC	$13.5M	3,018,907
SYSTEMATIC FINANCIAL MANAGEMENT LP	$12.7M	2,857,974
DIMENSIONAL FUND ADVISORS LP	$10.4M	2,340,901
ACADIAN ASSET MANAGEMENT LLC	$9.0M	2,022,119
RENAISSANCE TECHNOLOGIES LLC	$9.0M	2,014,903
GEODE CAPITAL MANAGEMENT, LLC	$8.1M	1,807,889

Companies Similar to OSUR

Ranked by quality-profile closeness and shared hedge-fund ownership — not just sector membership.

TMCI

TREACE MEDICAL CONCEPTS, INC.

AI score

Very similar · 5 shared holders

GAGNON SECURITIES LLC Gagnon Advisors, LLC JACOBS LEVY EQUITY MANAGEMENT, INC

ANGO

ANGIODYNAMICS INC

AI score

Similar quality profile · 6 shared holders

SYSTEMATIC FINANCIAL MANAGEMENT LP KOTLER KEVIN First Eagle Investment Management, LLC

LUNG

Pulmonx Corp

AI score

Similar quality profile · 3 shared holders

Kent Lake PR LLC KOTLER KEVIN JACOBS LEVY EQUITY MANAGEMENT, INC

MGX

Metagenomi Therapeutics, Inc.

AI score

Similar quality profile · 3 shared holders

Peapod Lane Capital LLC JACOBS LEVY EQUITY MANAGEMENT, INC Marquette Asset Management, LLC

ASRT

Assertio Holdings, Inc.

AI score

Similar quality profile · 1 shared holders

Sonora Investment Management Group, LLC

DCGO

DocGo Inc.

AI score

Similar quality profile · 3 shared holders

Peapod Lane Capital LLC Marquette Asset Management, LLC JACOBS LEVY EQUITY MANAGEMENT, INC

SIGA

SIGA TECHNOLOGIES INC

AI score

Similar quality profile · 4 shared holders

JACOBS LEVY EQUITY MANAGEMENT, INC Significant Wealth Partners LLC Headlands Technologies LLC

INGN

Inogen Inc

AI score

Similar quality profile · 4 shared holders

JACOBS LEVY EQUITY MANAGEMENT, INC Kent Lake PR LLC Peapod Lane Capital LLC

Similarity is computed from the 8 composite sub-scores and latest-quarter 13F conviction holdings (index-style filers excluded). Refreshed monthly.

More Healthcare Companies

View all Healthcare →

AAPG

ASCENTAGE PHARMA GROUP INTERNATIONAL

AARD

Aardvark Therapeutics, Inc.

ABBV

AbbVie Inc.

ABCL

AbCellera Biologics Inc.

ABEO

ABEONA THERAPEUTICS INC.

ABOS

Acumen Pharmaceuticals, Inc.

ABPWW

Abpro Holdings, Inc.

ABSI

Absci Corp

Put OSUR on your watchlist

Track score changes the day ORASURE TECHNOLOGIES INC files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Popular Research

AAPL

Apple

MSFT

Microsoft

NVDA

NVIDIA

GOOG

Alphabet

AMZN

Amazon

Is OSUR a good stock to buy?

13F Pro's AI-powered analysis of ORASURE TECHNOLOGIES INC (OSUR) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for OSUR are available on the OSUR stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. OSUR is classified as a small company.

Which hedge funds own OSUR?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling OSUR. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of ORASURE TECHNOLOGIES INC's investment landscape.